<VariationArchive VariationID="1073260" VariationName="NM_001849.4(COL6A2):c.998del (p.Lys333fs)" VariationType="Deletion" Accession="VCV001073260" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2022-05-16" MostRecentSubmission="2022-05-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1064928" VariationID="1073260">
      <GeneList>
        <Gene Symbol="COL6A2" FullName="collagen type VI alpha 2 chain" GeneID="1292" HGNC_ID="HGNC:2212" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46098112" stop="46132848" display_start="46098112" display_stop="46132848" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47518032" stop="47552762" display_start="47518032" display_stop="47552762" Strand="+" />
          </Location>
          <OMIM>120240</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001849.4(COL6A2):c.998del (p.Lys333fs)</Name>
      <CanonicalSPDI>NC_000021.9:46116811:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>21q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46116812" stop="46116812" display_start="46116812" display_stop="46116812" variantLength="1" positionVCF="46116811" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47536726" stop="47536726" display_start="47536726" display_stop="47536726" variantLength="1" positionVCF="47536725" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>K333fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.47536727del" Assembly="GRCh37">
            <Expression>NC_000021.8:g.47536727del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.46116813del" Assembly="GRCh38">
            <Expression>NC_000021.9:g.46116813del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008675.1" sequenceAccession="NG_008675" sequenceVersion="1" change="g.23695del">
            <Expression>NG_008675.1:g.23695del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001849.4" sequenceAccession="NM_001849" sequenceVersion="4" change="c.998del" MANESelect="true">
            <Expression>NM_001849.4:c.998del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001840.3" sequenceAccession="NP_001840" sequenceVersion="3" change="p.Lys333fs">
            <Expression>NP_001840.3:p.Lys333fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058174.3" sequenceAccession="NM_058174" sequenceVersion="3" change="c.998del" MANEPlusClinical="true">
            <Expression>NM_058174.3:c.998del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_478054.2" sequenceAccession="NP_478054" sequenceVersion="2" change="p.Lys333fs">
            <Expression>NP_478054.2:p.Lys333fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_058175.3" sequenceAccession="NM_058175" sequenceVersion="3" change="c.998del">
            <Expression>NM_058175.3:c.998del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_478055.2" sequenceAccession="NP_478055" sequenceVersion="2" change="p.Lys333fs">
            <Expression>NP_478055.2:p.Lys333fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_476" sequenceAccession="LRG_476">
            <Expression>LRG_476:g.23695del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2123628814" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001849.4(COL6A2):c.998del (p.Lys333fs) AND Bethlem myopathy 1A" Accession="RCV001386217" Version="2">
        <ClassifiedConditionList TraitSetID="5661">
          <ClassifiedCondition DB="MedGen" ID="CN029274">Bethlem myopathy 1A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-05-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-05-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-05-16" MostRecentSubmission="2022-05-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19884007</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20976770</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5661" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="492" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myopathy, benign congenital, with contractures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bethlem myopathy 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Bethlem myopathy 1A</ElementValue>
                <XRef ID="MONDO:0024530" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BTHLM1A</ElementValue>
                <XRef Type="MIM" ID="158810" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BTHLM1</ElementValue>
                <XRef Type="MIM" ID="158810" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Collagen VI-related dystrophies (COL6-RDs) represent a continuum of overlapping clinical phenotypes with Bethlem muscular dystrophy at the milder end, Ullrich congenital muscular dystrophy (UCMD) at the more severe end, and a phenotype in between UCMD and Bethlem muscular dystrophy, referred to as intermediate COL6-RD. Bethlem muscular dystrophy is characterized by a combination of proximal muscle weakness and joint contractures. Hypotonia and delayed motor milestones occur in early childhood; mild hypotonia and weakness may be present congenitally. By adulthood, there is evidence of proximal weakness and contractures of the elbows, Achilles tendons, and long finger flexors. The progression of weakness is slow, and more than two thirds of affected individuals older than age 50 years remain independently ambulatory indoors, while relying on supportive means for mobility outdoors. Respiratory involvement is not a consistent feature. UCMD is characterized by congenital weakness, hypotonia, proximal joint contractures, and striking hyperlaxity of distal joints. Decreased fetal movements are frequently reported. Some affected children acquire the ability to walk independently; however, progression of the disease results in a loss of ambulation by age ten to eleven years. Early and severe respiratory insufficiency occurs in all individuals, resulting in the need for nocturnal noninvasive ventilation (NIV) in the form of bilevel positive airway pressure (BiPAP) by age 11 years. Intermediate COL6-RD is characterized by independent ambulation past age 11 years and respiratory insufficiency that is later in onset than in UCMD and results in the need for NIV in the form of BiPAP by the late teens to early 20s. In contrast to individuals with Bethlem muscular dystrophy, those with intermediate COL6-RD typically do not achieve the ability to run, jump, or climb stairs without use of a railing.</Attribute>
                <XRef ID="NBK1503" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301676</ID>
                <ID Source="BookShelf">NBK1503</ID>
              </Citation>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="610" DB="Orphanet" />
              <XRef ID="CN029274" DB="MedGen" />
              <XRef ID="MONDO:0024530" DB="MONDO" />
              <XRef Type="MIM" ID="158810" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3112004" SubmissionDate="2022-05-04" DateLastUpdated="2022-05-16" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10683086|MedGen:CN029274" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001586356" DateUpdated="2022-05-16" DateCreated="2021-05-10" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19884007</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20976770</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Lys333Argfs*75) in the COL6A2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with COL6A2-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. Loss-of-function variants in COL6A2 are known to be pathogenic (PMID: 19884007, 20976770). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL6A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.47536726del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN029274" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3112004" TraitType="Disease" MappingType="XRef" MappingValue="CN029274" MappingRef="MedGen">
        <MedGen CUI="CN029274" Name="Bethlem myopathy 1A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

